Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medtronic
MedTech
Medtronic to spin out diabetes division as $2.8B company
The medtech giant said it aims to complete the spinoff within the next 18 months, with the goal of taking the new company public through an IPO.
Conor Hale
May 21, 2025 10:40am
HistoSonics considering a sale to major medtechs: report
May 2, 2025 11:30am
Medtronic sends Hugo robot in for FDA review
Apr 28, 2025 12:00pm
Medtronic nets FDA approval for Simplera Sync glucose tracker
Apr 21, 2025 11:00am
Medtronic inks stroke AI partnership with developer Methinks
Apr 2, 2025 11:54am
FDA approves Medtronic’s adaptive DBS implant for Parkinson’s
Feb 24, 2025 10:48am
